A pilot, multi-center, randomized, double-blind, placebo-controlled study to evaluate nesiritide infusion, initiated post-induction of anesthesia, in the management of coronary artery bypass graft (CABG) patients requiring cardiopulmonary bypass (CPB)

Trial Profile

A pilot, multi-center, randomized, double-blind, placebo-controlled study to evaluate nesiritide infusion, initiated post-induction of anesthesia, in the management of coronary artery bypass graft (CABG) patients requiring cardiopulmonary bypass (CPB)

Completed
Phase of Trial: Phase II

Latest Information Update: 31 Mar 2010

At a glance

  • Drugs Nesiritide (Primary)
  • Indications Heart failure
  • Focus Pharmacodynamics; Therapeutic Use
  • Acronyms NAPA
  • Sponsors Scios
  • Most Recent Events

    • 31 Mar 2010 Actual patient number (305) added as reported by ClinicalTrials.gov.
    • 31 Mar 2010 Actual patient number (305) added as reported by ClinicalTrials.gov.
    • 29 Apr 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top